Cystic Fibrosis
📧 Sign up to get email alerts when something new happens for Cystic Fibrosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-03-16Clinical Trial Update: Detection of Pseudomonas Aeruginosa in the Airways of Patients With CF [NA]
A completed clinical trial examining detection of Pseudomonas aeruginosa in the Airways of patients with cystic fibrosis, with results poste…
-
CLINICAL_TRIALS trial_result · 2021-03-01Clinical Trial Update: Testing the Effect of Adding Chronic Oral Azithromycin to Inhaled Tobramycin in People With Cystic Fibrosis (CF) [Phase 4]
Phase 4 trial updating the effects of adding chronic oral azithromycin to inhaled tobramycin in people with cystic fibrosis.
-
CLINICAL_TRIALS trial_result · 2021-02-11Clinical Trial Update: Improving Treatment of Nontuberculous Mycobacterial Infection in Cystic Fibrosis [NA]
Clinical trial update on improving treatment of nontuberculous mycobacterial infection in cystic fibrosis has completed; results posted in 2…
-
CLINICAL_TRIALS trial_result · 2021-02-03Clinical Trial Update: Safety, Efficacy, and Feasibility of High-dose Cholecalciferol in Pediatric Patients With Cystic Fibrosis [Phase 2]
Phase 2 trial updating safety, efficacy, and feasibility of high-dose vitamin D (cholecalciferol) in pediatric cystic fibrosis patients with…
-
CLINICAL_TRIALS trial_result · 2021-01-28Clinical Trial Update: A Study Evaluating the Safety of VX-152 Combination Therapy in Adults With Cystic Fibrosis [Phase 2]
Phase 2 trial evaluating safety of VX-152 combination therapy in adults with cystic fibrosis has completed; results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2021-01-14Clinical Trial Update: Epidemiology and Treatment of Small-colony Variant Staphylococcus Aureus in Cystic Fibrosis [Phase 4]
Phase 4 trial on epidemiology and treatment of small-colony variant Staphylococcus aureus in cystic fibrosis was withdrawn.
-
CLINICAL_TRIALS trial_result · 2021-01-12Clinical Trial Update: Aztreonam Aerosol to Treat Cystic Fibrosis Nasal Disease [Phase 2]
Phase 2 trial update for aztreonam aerosol in cystic fibrosis nasal disease was terminated; results have been posted.
-
CLINICAL_TRIALS trial_result · 2021-01-06Clinical Trial Update: Evaluating High Flow Humidification Therapy in Patients With Cystic Fibrosis [NA]
Clinical trial evaluating high flow humidification therapy in cystic fibrosis patients has completed with results posted.
-
FDA approval · 2020-12-21FDA Approved: KALYDECO — Supplemental Application (Vertex Pharmaceuticals Incorporated)
The FDA approved a supplemental application for KALYDECO (ivacaftor) filed by Vertex Pharmaceuticals Incorporated. The action authorizes cha…
-
FDA approval · 2020-12-21FDA Approved: SYMDEKO — Supplemental Application (Vertex Pharmaceuticals Incorporated)
The FDA approved a supplemental application for Symdeko (tezacaftor and ivacaftor) submitted by Vertex Pharmaceuticals Incorporated.
-
FDA approval · 2020-12-21FDA Approved: KALYDECO — Supplemental Application (Vertex Pharmaceuticals Incorporated)
The FDA approved a supplemental application for KALYDECO (ivacaftor) submitted by Vertex Pharmaceuticals Incorporated.
-
FDA approval · 2020-12-21FDA Approved: TRIKAFTA — Supplemental Application (Vertex Pharmaceuticals Incorporated)
The FDA approved a supplemental application for TRIKAFTA (elexacaftor/tezacaftor/ivacaftor) submitted by Vertex Pharmaceuticals Incorporated…
-
CLINICAL_TRIALS trial_result · 2020-12-19Clinical Trial Update: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QAU145 in Patients With Cystic Fibrosis [Phase 2]
Phase 2 clinical trial update assessing safety, tolerability, pharmacokinetics, and pharmacodynamics of QAU145 in patients with cystic fibro…
-
FDA approval · 2020-11-18FDA Approved: TRIKAFTA — Supplemental Application (Vertex Pharmaceuticals Incorporated)
FDA supplemental approval action for TRIKAFTA (elexacaftor/tezacaftor/ivacaftor) submitted by Vertex Pharmaceuticals; this action updates th…
-
CLINICAL_TRIALS trial_result · 2020-11-13Clinical Trial Update: Losartan and Inflammation in Cystic Fibrosis [Phase 2]
Phase 2 clinical trial investigating losartan for inflammation in cystic fibrosis; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2020-11-04Clinical Trial Update: Tobramycin Inhalation Powder (TIP) in Cystic Fibrosis Patients Infected With Burkholderia Cepacia Complex [Phase 1]
Phase 1 trial update for tobramycin inhalation powder in cystic fibrosis patients infected with Burkholderia cepacia complex; study complete…
-
CLINICAL_TRIALS trial_result · 2020-10-19Clinical Trial Update: Extension Study of Ataluren (PTC124) in Cystic Fibrosis [Phase 3]
Extension study update for ataluren (PTC124) in cystic fibrosis; Phase 3 completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-10-09Clinical Trial Update: Long Term Administration of Inhaled Mannitol in Cystic Fibrosis [Phase 3]
Phase 3 trial update on long-term inhaled mannitol administration for cystic fibrosis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-09-29Clinical Trial Update: Short Term Effects of Ivacaftor in Non-G551D Cystic Fibrosis Patients [NA]
A completed clinical trial evaluating short-term effects of ivacaftor in cystic fibrosis patients without the G551D mutation.
-
FDA approval · 2020-09-24FDA Approved: KALYDECO — Supplemental Application (Vertex Pharmaceuticals Incorporated)
The FDA approved a supplemental application for KALYDECO (ivacaftor) submitted by Vertex Pharmaceuticals Incorporated.
-
FDA approval · 2020-09-24FDA Approved: KALYDECO — Supplemental Application (Vertex Pharmaceuticals Incorporated)
FDA approved a supplemental application for KALYDECO (ivacaftor) from Vertex Pharmaceuticals Incorporated.
-
CLINICAL_TRIALS trial_result · 2020-09-24Clinical Trial Update: Exploratory Study to Evaluate QR-010 in Subjects With Cystic Fibrosis ΔF508 CFTR Mutation [Phase 1]
Phase 1 exploratory study of QR-010 in subjects with cystic fibrosis carrying the ΔF508 CFTR mutation has completed.
-
CLINICAL_TRIALS trial_result · 2020-09-03Clinical Trial Update: A Safety and Efficacy Trial of Inhaled Mannitol in Adult Cystic Fibrosis Subjects [Phase 3]
Phase 3 trial evaluating inhaled mannitol in adult cystic fibrosis patients has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-08-28Clinical Trial Update: A Study Evaluating the Safety and Efficacy of VX-440 Combination Therapy in Subjects With Cystic Fibrosis [Phase 2]
Phase 2 trial evaluating VX-440 combination therapy in cystic fibrosis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-08-26Clinical Trial Update: Study to Evaluate the Safety and Efficacy of CTP-656 in Patients With Cystic Fibrosis With CFTR Gating Mutations [Phase 2]
Phase 2 trial evaluating CTP-656 in cystic fibrosis with CFTR gating mutations was terminated; results posted.